Click here for Analysts' Upgrades, Downgrades.
Editor's Note: Green and red arrows refer to intraday stock price movement.
NEW YORK (TheStreet) -- STOCK COMMENTS / EPS CHANGES
Atlas Air Worldwide (AAWW) numbers boosted at Goldman. Shares of AAWW now seen reaching $59. Estimates also upped, given better freight demand. Neutral rating.American Express (AXP) price target boosted at Barclays. AXP price target jumped to $55 from $51. Purchase volumes continue to rebound. Maintain Overweight rating. Baker Hughes (BHI) price target raised at Citi to $56 from $49 after strong third-quarter results. Maintain Hold rating. Baker Hughes (BHI) numbers raised at UBS. Shares of BHI now seen reaching $52. Estimates also increased, because of higher expected international margins. Neutral rating. Ball (BLL) price target raised at Credit Suisse. BLL price target boosted to $69 from $64. 2011 offers quadruple play of growth. Maintain Outperform rating. Ball (BLL) price target raised at Credit Suisse to $69 from $64. 2011 offers quadruple play of growth. Maintain Outperform rating. Cognizant Technology (CTSH) numbers increased at Goldman. CTSH estimates were raised through 2012. Company is seeing higher sales demand. Neutral rating and new $71 price target. Discover Financial (DFS) price target higher at Barclays to $23 from $20. Credit trends pave the way to normalized EPS. Maintain Overweight rating. Endo Pharmaceuticals (ENDP) numbers raised at Oppenheimer. Shares of ENDP now seen reaching $42. Estimates also increased, given lower expenses. Outperform rating. Endo Pharmaceuticals (ENDP) numbers lowered at Goldman. Shares of ENDP now seen reaching $30. Estimates also cut, given lower sales across the board. Neutral rating.
Estee Lauder (EL) numbers boosted at Goldman. Shares of EL now seen reaching $72, according to Goldman Sachs. Estimates also upped, because of better cost controls. Neutral rating. Humana (HUM) target, estimate boosted at Barclays. HUM price target increased to $65 from $58. Earnings above expectations, Barclays said. 2010 EPS estimate raised to $6.50, 2011 maintained at $5.80. Reiterate Equal Weight rating. Humana (HUM) estimates, target upped at Goldman. HUM estimates were boosted through 2012. Company should be able to sustain some of its recent margin gains. Neutral rating and new $57 price target. Intercontinental Exchange (ICE) numbers increased at Goldman. ICE estimates were raised through 2012, Goldman Sachs said. Company is seeing better volume trends. Neutral rating and new $120 price target. L-3 Communications (LLL) price target cut at Barclays. LLL price target lowered to $92 from $100 as the company experienced organic growth slowdowns in third-quarter, Barclays said. Maintain Overweight rating. Magellan Health (MGLN) numbers upped at Goldman. MGLN estimates were boosted through 2012. Company is facing lower costs. Neutral rating and new $50 price target. Nabors Industries (NBR) cut from Conviction Buy List at Goldman. Company is approaching peak margins. Pactiv (PTV) estimates, target boosted at Goldman. Shares of PTV now seen reaching $33. Estimates also upped, because of better earnings momentum. Neutral rating. Rovi (ROVI) estimates, target raised at Goldman. Shares of ROVI now seen reaching $54. Estimates also increased, to match the company's new guidance. Neutral rating. Torchmark (TMK) estimates, target boosted at Goldman. Shares of TMK now seen reaching $62. Estimates also upped, given higher expected share buybacks. Neutral rating. Under Armour (UA) estimates increased at Morgan Stanley. UA estimates were raised through 2011. Company should improve its footwear operations. Equal-weight rating. United Stationers (USTR) added to Top Picks List at FBR Capital Markets. Sales should benefit from customer market share gains. MEMC Electronic (WFR) numbers lowered at UBS. WFR estimates were reduced through 2011, UBS said. Company is not growing its margins as quickly as expected. Buy rating and new $14.15 price target. MEMC Electronic (WFR) numbers upped at Goldman through 2012. Operating fundamentals are slowly improving Sell rating and new $9.50 price target. Zimmer Holdings (ZMH) price target cut at BofA/Merrill to $56 from $72 following disappointing third-quarter results. Maintain Buy rating.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV